Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1965 1
1967 1
1974 1
1980 1
1982 1
1983 1
1985 1
1986 1
1987 6
1988 3
1989 4
1990 1
1991 4
1992 12
1993 17
1994 18
1995 11
1996 22
1997 20
1998 22
1999 28
2000 31
2001 39
2002 45
2003 60
2004 76
2005 86
2006 86
2007 101
2008 136
2009 142
2010 165
2011 181
2012 233
2013 261
2014 269
2015 307
2016 291
2017 310
2018 394
2019 490
2020 595
2021 626
2022 691
2023 7
Text availability
Article attribute
Article type
Publication date

Search Results

5,195 results
Results by year
Filters applied: . Clear all
Page 1
Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions.
Yan Z, Chen B, Yang Y, Yi X, Wei M, Ecklu-Mensah G, Buschmann MM, Liu H, Gao J, Liang W, Liu X, Yang J, Ma W, Liang Z, Wang F, Chen D, Wang L, Shi W, Stampfli MR, Li P, Gong S, Chen X, Shu W, El-Omar EM, Gilbert JA, Blaser MJ, Zhou H, Chen R, Wang Z. Yan Z, et al. Among authors: wei m. Nat Microbiol. 2022 Sep;7(9):1361-1375. doi: 10.1038/s41564-022-01196-8. Epub 2022 Aug 22. Nat Microbiol. 2022. PMID: 35995842
Trial of Thrombectomy 6 to 24 Hours after Stroke Due to Basilar-Artery Occlusion.
Jovin TG, Li C, Wu L, Wu C, Chen J, Jiang C, Shi Z, Gao Z, Song C, Chen W, Peng Y, Yao C, Wei M, Li T, Wei L, Xiao G, Yang H, Ren M, Duan J, Liu X, Yang Q, Liu Y, Zhu Q, Shi W, Zhu Q, Li X, Guo Z, Yang Q, Hou C, Zhao W, Ma Q, Zhang Y, Jiao L, Zhang H, Liebeskind DS, Liang H, Jadhav AP, Wen C, Brown S, Zhu L, Ye H, Ribo M, Chang M, Song H, Chen J, Ji X; BAOCHE Investigators. Jovin TG, et al. Among authors: wei m. N Engl J Med. 2022 Oct 13;387(15):1373-1384. doi: 10.1056/NEJMoa2207576. N Engl J Med. 2022. PMID: 36239645 Clinical Trial.
PRMT5 regulates RNA m6A demethylation for doxorubicin sensitivity in breast cancer.
Wu Y, Wang Z, Han L, Guo Z, Yan B, Guo L, Zhao H, Wei M, Hou N, Ye J, Wang Z, Shi C, Liu S, Chen C, Chen S, Wang T, Yi J, Zhou J, Yao L, Zhou W, Ling R, Zhang J. Wu Y, et al. Among authors: wei m. Mol Ther. 2022 Jul 6;30(7):2603-2617. doi: 10.1016/j.ymthe.2022.03.003. Epub 2022 Mar 10. Mol Ther. 2022. PMID: 35278676
The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia.
Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, Zhou K, Li W, Hu J, Fu C, Aziz T, Li H, Li J, Yang Y, Han L, Zhang S, Ma Y, Sun M, Wu H, Zhang Z, Wunderlich M, Robinson S, Braas D, Hoeve JT, Zhang B, Marcucci G, Mulloy JC, Zhou K, Tao HF, Deng X, Horne D, Wei M, Huang H, Chen J. Weng H, et al. Among authors: wei m. Cancer Cell. 2022 Oct 26:S1535-6108(22)00495-0. doi: 10.1016/j.ccell.2022.10.004. Online ahead of print. Cancer Cell. 2022. PMID: 36306790
Safety and efficacy of mosunetuzumab, a bispecific antibody, in patients with relapsed or refractory follicular lymphoma: a single-arm, multicentre, phase 2 study.
Budde LE, Sehn LH, Matasar M, Schuster SJ, Assouline S, Giri P, Kuruvilla J, Canales M, Dietrich S, Fay K, Ku M, Nastoupil L, Cheah CY, Wei MC, Yin S, Li CC, Huang H, Kwan A, Penuel E, Bartlett NL. Budde LE, et al. Among authors: wei mc. Lancet Oncol. 2022 Aug;23(8):1055-1065. doi: 10.1016/S1470-2045(22)00335-7. Epub 2022 Jul 5. Lancet Oncol. 2022. PMID: 35803286 Clinical Trial.
Antibacterial metal nanoclusters.
Zheng Y, Wei M, Wu H, Li F, Ling D. Zheng Y, et al. Among authors: wei m. J Nanobiotechnology. 2022 Jul 16;20(1):328. doi: 10.1186/s12951-022-01538-y. J Nanobiotechnology. 2022. PMID: 35842693 Free PMC article. Review.
An Fc-Competent Anti-Human TIGIT Blocking Antibody Ociperlimab (BGB-A1217) Elicits Strong Immune Responses and Potent Anti-Tumor Efficacy in Pre-Clinical Models.
Chen X, Xue L, Ding X, Zhang J, Jiang L, Liu S, Hou H, Jiang B, Cheng L, Zhu Q, Zhang L, Zhou X, Ma J, Liu Q, Li Y, Ren Z, Jiang B, Song X, Song J, Jin W, Wei M, Shen Z, Liu X, Wang L, Li K, Zhang T. Chen X, et al. Among authors: wei m. Front Immunol. 2022 Feb 22;13:828319. doi: 10.3389/fimmu.2022.828319. eCollection 2022. Front Immunol. 2022. PMID: 35273608 Free PMC article.
5,195 results